ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation
Ann Oncol
.
2014 Sep:25 Suppl 3:iii143-52.
doi: 10.1093/annonc/mdu238.
Authors
N I Cherny
1
;
ESMO Guidelines Working Group
Collaborators
ESMO Guidelines Working Group
:
Andrés Cervantes
,
George Pentheroudakis
,
Enriqueta Felip
,
Nicholas Pavlidis
,
Rolf A Stahel
,
Fatima Cardoso
,
Elzbieta Senkus-Konefka
,
Dirk Arnold
,
Philippe Rougier
,
Alan Horwich
,
Cristiana Sessa
,
Nicoletta Colombo
,
Lisa Licitra
,
Christian Buske
,
Marco Ladetto
,
Solange Peters
,
Paolo Casali
,
Ulrich Keilholz
,
Nathan Cherny
,
Jørn Herrstedt
Affiliation
1
Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
PMID:
25210083
DOI:
10.1093/annonc/mdu238
No abstract available
Publication types
Practice Guideline
MeSH terms
Health Planning Guidelines*
Humans
Hypnotics and Sedatives / therapeutic use*
Neoplasms / complications*
Pain / drug therapy*
Pain / etiology
Palliative Care*
Prognosis
Societies, Medical / standards*
Terminal Care*
Substances
Hypnotics and Sedatives